Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11

Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11

Patients with cerebrovascular disease (CeVD) have been shown to benefit from lipid-lowering therapies, but guideline-recommended levels of low-density lipoprotein cholesterol (LDL-C) are often not attained with statin treatment alone. The ORION-9, ORION-10, and ORION-11 trials evaluated the efficacy...

Full description

Bibliographic Details
Main Authors: Wolfgang Koenig, Kausik K. Ray, Ulf Landmesser, Lawrence A. Leiter, Gregory G. Schwartz, R. Scott Wright, Lorena Garcia Conde, Jackie Han, Frederick J. Raal
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:American Journal of Preventive Cardiology
Subjects:
Inclisiran
siRNA
Cerebrovascular disease
LDL-cholesterol
Safety
Online Access:http://www.sciencedirect.com/science/article/pii/S2666667723000442

Internet

http://www.sciencedirect.com/science/article/pii/S2666667723000442

Similar Items